FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069713478> ?p ?o ?g. }

• W2069713478 abstract "We have shown that continuous systemic delivery of interferon beta (IFN-β) remodels dysfunctional tumor vasculature, thereby improving tumor perfusion and enhancing delivery and efficacy of chemotherapeutic drugs. We hypothesized that because of their inherent tumor tropism, neural progenitor cells (NPCs) engineered to express IFN-β could also effect maturation of tumor vasculature without generating high systemic levels of IFN-β. Mice with luciferase-expressing disseminated human neuroblastoma were divided into four groups of equal tumor burden by bioluminescence imaging: (1) untreated controls; (2) NPC-IFN-β only; (3) cyclophosphamide (CTX) only; and (4) NPC-IFN-β in combination with CTX. Two million NPC-IFN-β cells were administered twice, 7 days apart, starting 21 days after tail vein administration of tumor cells. CTX was administered every 6 days for three doses. Mice were killed at 6 weeks, livers and kidneys weighed, and tumor removed for immunohistochemical staining for endothelial cells (CD34), pericytes (α-SMA), apoptosis (TUNEL [terminal deoxynucleotidyl transferase dUTP nick-end labeling]), and diI-labeled NPCs. Fluorescent-labeled NPCs confirmed localization of these cells to tumors. The α-SMA/CD34 ratio, a marker for vascular maturation, greatly increased in NPC-IFN-β-treated tumors compared with controls. Bioluminescent signal from luciferase-expressing tumor cells, reflecting tumor burden, was lower with combination therapy than control or either monotherapy, and combination therapy resulted in far less tumor burden by weight in the kidneys and liver. Targeted delivery of IFN-β with NPCs produced low circulating levels of IFN-β, yet the maturing effect on the tumor vasculature and the enhanced efficacy of adjuvant therapy was maintained. Thus, combination therapy of NPC-IFN-β with CTX warrants further investigation for the treatment of high-risk neuroblastoma patients." @default.
• W2069713478 created "2016-06-24" @default.
• W2069713478 creator A5002679589 @default.
• W2069713478 creator A5005743292 @default.
• W2069713478 creator A5032094946 @default.
• W2069713478 creator A5037050761 @default.
• W2069713478 creator A5039783551 @default.
• W2069713478 creator A5040109906 @default.
• W2069713478 creator A5063456712 @default.
• W2069713478 creator A5067791758 @default.
• W2069713478 creator A5068645990 @default.
• W2069713478 date "2008-08-23" @default.
• W2069713478 modified "2023-10-10" @default.
• W2069713478 title "Neural Progenitor Cell-mediated Delivery of Interferon Beta Improves Neuroblastoma Response to Cyclophosphamide" @default.
• W2069713478 cites W130696028 @default.
• W2069713478 cites W1570839422 @default.
• W2069713478 cites W1603230122 @default.
• W2069713478 cites W1968134787 @default.
• W2069713478 cites W1971231025 @default.
• W2069713478 cites W1973799102 @default.
• W2069713478 cites W1977887541 @default.
• W2069713478 cites W1978375745 @default.
• W2069713478 cites W1980441719 @default.
• W2069713478 cites W1983533157 @default.
• W2069713478 cites W1984583580 @default.
• W2069713478 cites W1995968681 @default.
• W2069713478 cites W2002693051 @default.
• W2069713478 cites W2003079845 @default.
• W2069713478 cites W2004390887 @default.
• W2069713478 cites W2006351633 @default.
• W2069713478 cites W2051976924 @default.
• W2069713478 cites W2053762083 @default.
• W2069713478 cites W2062359341 @default.
• W2069713478 cites W2068375644 @default.
• W2069713478 cites W2078199984 @default.
• W2069713478 cites W2085546686 @default.
• W2069713478 cites W2097196308 @default.
• W2069713478 cites W2111444340 @default.
• W2069713478 cites W2121699071 @default.
• W2069713478 cites W2126502536 @default.
• W2069713478 cites W2132416992 @default.
• W2069713478 cites W2135212691 @default.
• W2069713478 cites W2140403987 @default.
• W2069713478 cites W2327522594 @default.
• W2069713478 cites W4242270309 @default.
• W2069713478 doi "https://doi.org/10.1245/s10434-008-0103-z" @default.
• W2069713478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2587051" @default.
• W2069713478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18726131" @default.
• W2069713478 hasPublicationYear "2008" @default.
• W2069713478 type Work @default.
• W2069713478 sameAs 2069713478 @default.
• W2069713478 citedByCount "11" @default.
• W2069713478 countsByYear W20697134782012 @default.
• W2069713478 countsByYear W20697134782013 @default.
• W2069713478 countsByYear W20697134782017 @default.
• W2069713478 countsByYear W20697134782022 @default.
• W2069713478 crossrefType "journal-article" @default.
• W2069713478 hasAuthorship W2069713478A5002679589 @default.
• W2069713478 hasAuthorship W2069713478A5005743292 @default.
• W2069713478 hasAuthorship W2069713478A5032094946 @default.
• W2069713478 hasAuthorship W2069713478A5037050761 @default.
• W2069713478 hasAuthorship W2069713478A5039783551 @default.
• W2069713478 hasAuthorship W2069713478A5040109906 @default.
• W2069713478 hasAuthorship W2069713478A5063456712 @default.
• W2069713478 hasAuthorship W2069713478A5067791758 @default.
• W2069713478 hasAuthorship W2069713478A5068645990 @default.
• W2069713478 hasBestOaLocation W20697134782 @default.
• W2069713478 hasConcept C10205521 @default.
• W2069713478 hasConcept C111335760 @default.
• W2069713478 hasConcept C142724271 @default.
• W2069713478 hasConcept C154113507 @default.
• W2069713478 hasConcept C161997846 @default.
• W2069713478 hasConcept C196795494 @default.
• W2069713478 hasConcept C201750760 @default.
• W2069713478 hasConcept C204232928 @default.
• W2069713478 hasConcept C2776715637 @default.
• W2069713478 hasConcept C28328180 @default.
• W2069713478 hasConcept C502942594 @default.
• W2069713478 hasConcept C54009773 @default.
• W2069713478 hasConcept C54355233 @default.
• W2069713478 hasConcept C71924100 @default.
• W2069713478 hasConcept C81885089 @default.
• W2069713478 hasConcept C86803240 @default.
• W2069713478 hasConceptScore W2069713478C10205521 @default.
• W2069713478 hasConceptScore W2069713478C111335760 @default.
• W2069713478 hasConceptScore W2069713478C142724271 @default.
• W2069713478 hasConceptScore W2069713478C154113507 @default.
• W2069713478 hasConceptScore W2069713478C161997846 @default.
• W2069713478 hasConceptScore W2069713478C196795494 @default.
• W2069713478 hasConceptScore W2069713478C201750760 @default.
• W2069713478 hasConceptScore W2069713478C204232928 @default.
• W2069713478 hasConceptScore W2069713478C2776715637 @default.
• W2069713478 hasConceptScore W2069713478C28328180 @default.
• W2069713478 hasConceptScore W2069713478C502942594 @default.
• W2069713478 hasConceptScore W2069713478C54009773 @default.
• W2069713478 hasConceptScore W2069713478C54355233 @default.
• W2069713478 hasConceptScore W2069713478C71924100 @default.
• W2069713478 hasConceptScore W2069713478C81885089 @default.
• W2069713478 hasConceptScore W2069713478C86803240 @default.
• W2069713478 hasIssue "11" @default.

• next